S. Rodríguez-Fernández

发表

Type 1 Diabetes Prevention in NOD Mice by Targeting DPPIV/CD26 Is Associated with Changes in CD8+T Effector Memory Subset

M. Puig-Domingo, R. Colobran, N. Alonso, 2015, PloS one.

Partial remission and early stages of pediatric type 1 diabetes display immunoregulatory changes. A pilot study.

R. Planas, S. Rodríguez-Fernández, M. Vives-Pi, 2019, Translational research : the journal of laboratory and clinical medicine.

Candidate Biomarkers for the Prediction and Monitoring of Partial Remission in Pediatric Type 1 Diabetes

Federico Vázquez, L. Castano, S. Rodríguez-Fernández, 2022, Frontiers in Immunology.

Immune System Remodelling by Prenatal Betamethasone: Effects on β-Cells and Type 1 Diabetes

S. Rodríguez-Fernández, M. Vives-Pi, A. Gieras, 2020, Frontiers in Endocrinology.

A century later, still fighting back: antigen‐specific immunotherapies for type 1 diabetes

S. Rodríguez-Fernández, M. Vives-Pi, David Perna-Barrull, 2021, Immunology and cell biology.

Impaired Phagocytosis in Dendritic Cells From Pediatric Patients With Type 1 Diabetes Does Not Hamper Their Tolerogenic Potential

D. Maspoch, Federico Vázquez, S. Rodríguez-Fernández, 2019, Front. Immunol..

Prenatal Betamethasone interferes with immune system development and alters target cells in autoimmune diabetes

I. Pujol-Autonell, S. Rodríguez-Fernández, M. Vives-Pi, 2019, Scientific Reports.

Current development of alternative treatments for endothelial decompensation: Cell-based therapy.

S. Rodríguez-Fernández, I. Fuentes-Boquete, C. Sanjurjo-Rodríguez, 2021, Experimental eye research.

A role for Oncostatin M in the impairment of glucose homeostasis in obesity.

F. Villarroya, C. Lerin, M. Puig-Domingo, 2019, The Journal of clinical endocrinology and metabolism.

Use of Autoantigen-Loaded Phosphatidylserine-Liposomes to Arrest Autoimmunity in Type 1 Diabetes

M. Puig-Domingo, D. Maspoch, T. Stratmann, 2015, PloS one.

Prenatal Betamethasone Exposure and its Impact on Pediatric Type 1 Diabetes Mellitus: A Preliminary Study in a Spanish Cohort

M. Puig-Domingo, S. Rodríguez-Fernández, M. Vives-Pi, 2022, Journal of diabetes research.

Repurposed Analog of GLP-1 Ameliorates Hyperglycemia in Type 1 Diabetic Mice Through Pancreatic Cell Reprogramming

Federico Vázquez, I. Pujol-Autonell, S. Rodríguez-Fernández, 2020, Frontiers in Endocrinology.

Immortalizing Mesenchymal Stromal Cells from Aged Donors While Keeping Their Essential Features

S. Rodríguez-Fernández, S. Díaz-Prado, I. Fuentes-Boquete, 2020, Stem cells international.

Preclinical evaluation of antigen-specific nanotherapy based on phosphatidylserine-liposomes for type 1 diabetes

D. Maspoch, S. Rodríguez-Fernández, M. Vives-Pi, 2020, Artificial cells, nanomedicine, and biotechnology.

Sustained spontaneous partial remission in a pediatric patient with type 1 diabetes

L. Bosch, Federico Vázquez, S. Rodríguez-Fernández, 2017 .

CD26/DPPIV inhibition alters the expression of immune response-related genes in the thymi of NOD mice

M. Puig-Domingo, R. Colobran, N. Alonso, 2016, Molecular and Cellular Endocrinology.

Impact of Betamethasone Pretreatment on Engrafment of Cord Blood-Derived Hematopoietic Stem Cells

S. Rodríguez-Fernández, M. Vives-Pi, S. Querol, 2022, Archivum immunologiae et therapiae experimentalis.

A new platform for autoimmune diseases. Inducing tolerance with liposomes encapsulating autoantigens.

G. Schett, S. Rodríguez-Fernández, M. Vives-Pi, 2022, Nanomedicine : nanotechnology, biology, and medicine.

Analysis of Cryopreservation Protocols and Their Harmful Effects on the Endothelial Integrity of Human Corneas

S. Rodríguez-Fernández, S. Díaz-Prado, I. Fuentes-Boquete, 2021, International Journal of Molecular Sciences.

Tips and tricks for successfully culturing and adapting human induced pluripotent stem cells

S. Rodríguez-Fernández, S. Díaz-Prado, I. Fuentes-Boquete, 2021, Molecular therapy. Methods & clinical development.

Versatility of Induced Pluripotent Stem Cells (iPSCs) for Improving the Knowledge on Musculoskeletal Diseases

F. Blanco, S. Rodríguez-Fernández, S. Díaz-Prado, 2020, International journal of molecular sciences.

Phosphatidylserine-Liposomes Promote Tolerogenic Features on Dendritic Cells in Human Type 1 Diabetes by Apoptotic Mimicry

Ferran Briansó, D. Maspoch, Federico Vázquez, 2018, Front. Immunol..

Generation and characterization of human induced pluripotent stem cells (iPSCs) from hand osteoarthritis patient-derived fibroblasts

I. Fuentes, J. de Toro, N. Oreiro, 2020, Scientific Reports.

Generation of human immortalized chondrocytes from osteoarthritic and healthy cartilage

S. Rodríguez-Fernández, S. Díaz-Prado, I. Fuentes-Boquete, 2023, Bone & joint research.

Antigen-specific immunotherapy combined with a regenerative drug in the treatment of experimental type 1 diabetes

D. Maspoch, Federico Vázquez, I. Pujol-Autonell, 2020, Scientific Reports.

Liposome-based immunotherapy against autoimmune diseases: therapeutic effect on multiple sclerosis.

D. Maspoch, I. Pujol-Autonell, S. Rodríguez-Fernández, 2017, Nanomedicine.

Immunoregulatory Biomarkers of the Remission Phase in Type 1 Diabetes: miR-30d-5p Modulates PD-1 Expression and Regulatory T Cell Expansion

S. Rodríguez-Fernández, M. Vives-Pi, David Perna-Barrull, 2023, Non-coding RNA.

NK Cell Subsets Changes in Partial Remission and Early Stages of Pediatric Type 1 Diabetes

Federico Vázquez, S. Rodríguez-Fernández, M. Vives-Pi, 2021, Frontiers in Immunology.

Usefulness of Mesenchymal Cell Lines for Bone and Cartilage Regeneration Research

F. Blanco, S. Rodríguez-Fernández, S. Díaz-Prado, 2019, International journal of molecular sciences.

Generation of Mesenchymal Cell Lines Derived from Aged Donors

S. Rodríguez-Fernández, S. Díaz-Prado, I. Fuentes-Boquete, 2021, International journal of molecular sciences.

How apoptotic β-cells direct immune response to tolerance or to autoimmune diabetes: a review

I. Pujol-Autonell, S. Rodríguez-Fernández, M. Vives-Pi, 2015, Apoptosis.